PLX-300

N/A

Report date: 2024/01/09 14:58:21
NME

Base Information

Drug NamePLX-300
Drug Alias NamePLX-300
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsNiemann-Pick Disease, Type BNiemann-Pick Disease, Type ATay-Sachs Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPolaryx Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesPolaryx Therapeutics
Inactive CompaniesN/A
Active IndicationsNiemann-Pick Disease, Type BNiemann-Pick Disease, Type ATay-Sachs Disease +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A